CLS Holdings USA focuses on the extraction of various cannabinoids from the marijuana plant and conversion into concentrates, such as oils, waxes, edibles, and shatters for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories.
CLS is another fully integrated cannabis company that we think has potential. The company is executing a roll-up and consolidation strategy which will help it build an underlying cash-flow business to support it’s medical R&D efforts with its proprietary method of extracting various cannabinoids from the marijuana plant.
In December, the company entered into an agreement to acquire Oasis Cannabis which is a cannabis dispensary located in Las Vegas, Nevada that provides delivery services to patients using medical cannabis. If CLS is able to complete the Oasis acquisition this quarter, the company should be well positioned to grow its retail business and continue its acquisition strategy.